To see the action of homoeopathic medicine in the disease stye and to compare the homoeopathic medicines and biochemic medicines and to see which medicines are more effective 40 participants are included in the study out of which 20 are divided in group a and 20 are divided in group b

The requested reference [3c1707d671559dfddf9ed71be64c13312435c3fc] no longer exists in our database. It has been replaced by the current reference: [fde269c4f9d23309a7c8661b20db7ff5e6fcaa80]

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2026
INTERVENTION: Intervention1: Homoeopathic medicines Biochemic remedies: Patients are divided in 2 groups group A homoeopathic medicines group B biochemic remedies depending upon the case history the suitable medicine will be prescribed in suitable potency and dosage according to homooeopathic principles. Intervention2: Group A homoeopathic medicines : patients will be divided in 2 groups so group A patients will be given the medicines other than biochemic medicines rest all other homoeopathic drugs will be given in group a depending upon the history , totality of symtoms and suitable potency Control Intervention1: Nil: Nil Control Intervention2: Group B Biochemic medicines: As patients are divided in 2 groups so in comparator group b biochemic medicines will be given depending upon the history , totality of symtoms and suitable potency. CONDITION: Health Condition 1: H000‐ Hordeolum (externum) (internum) ofeyelid PRIMARY OUTCOME: to stop the the recurrence of stue and to see whether the homoeopathic medicines are more effective or biochemic medicines are more effective in management of styeTimepoint: Baseline day 0 ; initial clinical evaluation and case taking ; pain will be assessed using the pain scale ; first follow up day 3 ; clinical assessment of symptoms and monitoring response of homoeopathic medicines ; second follow up day 5 ; reassessment of symtoms if stye is not reducing ; Third follow up day 7 ; evaluation of clinical improvement and to determine treatment effectiveness ; SECONDARY OUTCOME: NilTimepoint: INCLUSION CRITERIA: 1 Male and female aged 16‐50 years 2 All stye shall be included after clinical examination, pathological investigation where necessary 3 patient with regular follow up
Epistemonikos ID: 6fa58b6f8ff9df58deadc98a45d94e4455d25235
First added on: Jul 25, 2026